← Back to research updates

ClinicalTrials.gov · Trial registry entry · 2026-11-13

Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic Medications

Reading list (0) →

Saved in this browser. Sign in to sync across devices.

WHAT THIS SOURCE TELLS US

ClinicalTrials.gov listing updated 2026-11-13. Status: RECRUITING; phase: PHASE3. Registration is not proof of benefit or safety.

What is the evidence status?

This is a registry record for a planned or ongoing study. Registration and recruitment do not show that the intervention is effective or safe.

Automatically indexed from an official source. This item has not received a NeuroCoach clinical review.

Read the original source

Open the original ClinicalTrials.gov record ↗

Questions worth asking

  • Which diagnosis and age group did this study actually examine?
  • Was there a control group and were clinically meaningful outcomes reported?
  • What was the safety follow-up, especially for people with several diagnoses?
  • Does a clinician familiar with the person’s history think it is relevant?

Research updates are educational, not individual medical advice. Do not start or stop any treatment based on a headline.